Group 1 - The core issue involves Xilong Science Co., Ltd. being penalized for inflating revenue and profits through fictitious trading activities in ethylene glycol and methanol during the years 2020 and 2021, as revealed by the China Securities Regulatory Commission [1] - The company has been fined and responsible individuals have been held accountable for their actions, which were disclosed in a correction announcement on April 29, 2023 [1] - A final ruling by the Guangdong High People's Court confirmed that the company must compensate 82 investors for losses amounting to over 7.57 million yuan, indicating judicial support for investor claims [1] Group 2 - The conditions for compensation state that investors who purchased Xilong Science stock between April 29, 2021, and April 29, 2023, and either sold or continued to hold the stock after April 29, 2023, are eligible for claims [2] - Required documentation for claims includes original transaction statements stamped by the brokerage, copies of the investor's ID, a confirmation of the securities account from the brokerage, and the investor's contact information [2] Group 3 - The lawyer, Niu Bin, indicated that the compensation registration conditions are based on existing judicial decisions and interpretations, and the final conditions will be determined by the court [3]
西陇科学诉讼时效临近 请受损投资者抓紧时间上车